Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.
Diabetol Metab Syndr. 2022 Nov 17;14(1):170. doi: 10.1186/s13098-022-00951-5.
Diabetol Metab Syndr. 2022.
PMID: 36397128
Free PMC article.
Cite
Cite